ATGP0824-100ug
|
NKMax Bio (ATGen)
|
GRP78/HSPA5 [20-650 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
ATGP0824-500ug
|
NKMax Bio (ATGen)
|
GRP78/HSPA5 [20-650 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
HY-10224-10mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-100mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-200mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-5mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-50mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-500mg
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7]
|
|
Cancer-programmed cell death
|
|
HY-10224-1mL
|
MedChemexpress LLC
|
Panobinostat [CAS 404950-80-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-153383-10mg
|
MedChemexpress LLC
|
PDCD4-IN-1 [CAS 494763-64-3]
|
|
|
|
HY-153383-100mg
|
MedChemexpress LLC
|
PDCD4-IN-1 [CAS 494763-64-3]
|
|
|
|
HY-153383-25mg
|
MedChemexpress LLC
|
PDCD4-IN-1 [CAS 494763-64-3]
|
|
|
|
HY-153383-5mg
|
MedChemexpress LLC
|
PDCD4-IN-1 [CAS 494763-64-3]
|
|
|
|
HY-153383-50mg
|
MedChemexpress LLC
|
PDCD4-IN-1 [CAS 494763-64-3]
|
|
|
|
HY-133131-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
HY-133131-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
HY-133131-25mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
HY-133131-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
HY-133131-50mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
HY-155978-1mg
|
MedChemexpress LLC
|
RDN2150 [CAS 2839429-51-3]
|
|
|
|
HY-155978-10mg
|
MedChemexpress LLC
|
RDN2150 [CAS 2839429-51-3]
|
|
|
|
HY-155978-25mg
|
MedChemexpress LLC
|
RDN2150 [CAS 2839429-51-3]
|
|
|
|
HY-155978-5mg
|
MedChemexpress LLC
|
RDN2150 [CAS 2839429-51-3]
|
|
|
|
HY-155978-50mg
|
MedChemexpress LLC
|
RDN2150 [CAS 2839429-51-3]
|
|
|
|
HY-152775-1mg
|
MedChemexpress LLC
|
RK-701 [CAS 2648855-18-7]
|
|
Cancer-programmed cell death
|
|